invest in the future of AI
AIXCS [ak·ses] is helping create a future where AI empowers healthier, safer, and more prosperous lives. Using AI-powered predictive analytics, we aim to drive greater investment into innovation and technology to solve humanities greatest challenges.
our purpose
Imagine a world where you can invest with greater confidence, take less risk, and make more money while helping bridge the $4 trillion annual funding gap to meet global sustainable development goals.
A better future for all
AIXCS is helping investors do exactly that by identifying the X factor for investment success. Our AI-powered systems help investors reduce risk, and improve profitability, driving more investment capital in innovation and technology.
Our mission
Drive more investment in technology by making venture investing less risky, more profitable, and easily accessible to everyone, everywhere.
Our vision
Positively impact the lives of one billion people by 2030 by driving investment in sustainable ventures and technology. We envision a future where AI not only streamlines processes and increases efficiency but helps us address pressing global challenges, from healthcare to climate change.
Our technology
AIXCS leverages artificial intelligence (AI) to develop more accurate and timely risk and asset management systems. Transforming how individuals and organizations make investment decisions.
driving intelligent decisions
Our intelligent systems focus on predictive analytics to evaluate the potential risks and opportunities in technology ventures. Using a multitude of data, our analytics determine fair value, business growth drivers, operating and technology risks, and much more to effectively determine the probability of success.Helping empower investors with the ability to overcome human limitations, eliminate personal biases, and make faster, more accurate investment decisions.
invest in your future
Year to date, our investment analytics have delivered a 40% return on invested capital in a proprietary trading portfolio (as of September 2024). Significantly outperforming venture capital and small and micro-cap investment benchmarks.In 2025, we are launching the first-of-its-kind exchange traded venture fund (ETVF) powered by AIXCS analytics to provide retail investors access to AI investing with the liquidity and transparency they would expect from a publicly listed entity. Enabling not just a few but many investors access to the exponential growth opportunity offered by advancements in AI.Join the pre-IPO whitelist for more information and early access.
Whitelisted investors are under no obligation to invest.
Step 1 - Complete Whitelist Form (5 mins)
The application is private and confidential and your contact information will be for the sole purposes of us deternining your investor status as either sophisticated, accredited, or retail investor.
Step 2 - get share allocation
All applications will be reviewed on a first come first basis. Whitelisted investors will be given an a maximum investment amount allocation.
Step 3 - Review offering documents
We will announce our pre-IPO offering terms first and foremost to all whitelisted investors. Giving you the opportunity to invest an amount of your choosing and up to the maximum amount allocated.
This is an unique opportunity to invest and benefit from the significant upside potential AIXCS as we develop AI-driven solutions across finance, healthcare and enterprise markets.
Together we can create a brighter future where possibilities are limitless and prosperity is within everyone's grasp.For more information, call +44 2081 444076
or email investors @ aixcs.ai
Disclaimer: AIXCS does not provide investment, financial, tax or legal advice. Nothing published or made available on this website should be considered personalized investment or financial advice, investment services or a solicitation to buy, sell, or hold any securities in any jurisdiction where it is not permitted by law. All information on the website is provided on an “as is” basis without representations.
Our people
We believe the best way to solve humanity's greatest challenges is to enable more funding in innovation and technology. The best way to do that is by making venture investing less risky and more accessible. Our leadership team brings over 100 years of combined experience across technology, business, and finance. It is further supported by a network of partners and associates across North America, Europe, the Middle East, and South and Far East Asia.Together we are positioning AIXCS as the market leader in AI-driven venture investment analytics and asset management.
Leadership Team
Suhail Ahmad, MBA
President and CEO
Suhail is an entrepreneurial leader with 27+ years of financial services, technology and capital markets experience. Suhail is passionate about unlocking human potential and making capital less risky, more inclusive.
Aisha Elahi
VP - Marketing
Aisha brings 22+ years of marketing and brand development experience working for start-ups and small-medium enterprises in North America and Europe across consumer products, finance, and professional services.
Mohamed Hammadi, MBA
VP - Finance
Mohamed brings 24+ years of accounting, corporate finance and global markets experience with leadership roles at multinationals such as GSK, Accenture, and Arthur Bonnet during his career.
Sheila Robinson
VP - Commercial
Sheila brings 30+ years of business development and commercialization experience working with start-ups across the U.K., Europe, and Canada in enterprise software, AI, telecom, and renewable energy sector.
join our team
Are you ready to shape the future?Join AIXCS and be part of a global team transforming venture investing and driving meaningful positive impact in the world.We're seeking passionate graduates and experienced professionals in technology, business, marketing, and finance. Whether you're a coding whiz, a creative problem-solver, or a strategic thinker, we may have a place for you.Email careers [@] aixcs.ai with your CV for consideration.
AIXCURE - FUTURE OF HEALTHCARE
aiXcure is a healthcare platform connecting scientists, investors, corporates, and industry professionals to latest in AI research and solutions helping us prevent, treat, and cure disease.
Subscribe to AIXCURE for news on AI in healthcare and launch updates:
Contact Us
AIXCS Ltd is a company registered in England and Wales, U.K.
Company registration number is 14847763
Office hours: Mon - Fri 8am - 6pm / Sat 8am - 2pm
63 Hatton Garden, London EC1N 8LE, United KingdomFor more information, please contact our team:
Whitelist application
We appreciate the opportunity to have you as a valued investor in AIXCS and our AI-powered exchange-traded venture fund.Please click the link below to access the application.
Thank you
Thank you for joining our whitelist. We will review your information and be in touch with more details as they become available.In the meantime, please send a quick 'hi' email to [email protected] to whitelist our email address and avoid any investor emails going inadvertently to your spam folder.
Cookies and Privacy Policy
Effective Date: May 1st, 2024IntroductionAixcs Ltd ("we," "us," or "our") is committed to protecting your privacy and ensuring transparency about how we use cookies and similar technologies on our website, aixcs.ai (the "Website").This policy explains what cookies are, how we use them, and your choices regarding their use.What are Cookies?Cookies are small text files that are stored on your computer or mobile device when you visit a website. They are widely used to make websites work efficiently, as well as to provide information to the website owners.How We Use CookiesWe use the following types of cookies on our Website:Strictly Necessary Cookies: These cookies are essential for the Website to function properly. They enable you to navigate the Website and use its features.Performance Cookies: These cookies collect anonymous information about how visitors use our Website, such as which pages are visited most often and if any error messages occur. This helps us improve the performance of the Website.Functionality Cookies: These cookies allow the Website to remember choices you make (such as your username, language, or region) and provide enhanced, personalized features.Third-Party CookiesWe may also allow certain trusted third parties to place cookies on our Website. These third parties may include analytics providers, advertising networks, and social media platforms. The information collected by these third parties is subject to their own privacy policies.Your Cookie ChoicesYou can control and manage cookies in various ways:Browser Settings: Most web browsers allow you to control cookies through their settings preferences. You can usually choose to block cookies or receive a notification when a cookie is being placed on your device.Cookie Consent Tool: Our Website uses a cookie consent tool that allows you to manage your cookie preferences.Your PrivacyWe respect your privacy and will never sell your personal data. The information we collect through cookies is generally anonymous and does not directly identify you. However, if you provide us with personal information (e.g., by filling out a contact form), we may link that information to the data collected through cookies.For more information about how we handle your personal data, please see our Privacy Policy.Changes to This Policy
We may update this Cookie Policy from time to time to reflect changes in our practices or for other operational, legal, or regulatory reasons. We encourage you to review this policy periodically.Contact UsIf you have any questions about this Cookie Policy or our use of cookies, please contact us at [email protected]